Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chugai Pharmaceutical Co. Ltd (CHGCF)

Chugai Pharmaceutical Co. Ltd (CHGCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Chugai Pharmaceutical Co. Ltd

Description:

Chugai Pharmaceutical Co Ltd was established on March 8, 1943. The Company is engaged in the manufacture, sale, import and export of pharmaceutical products. Its branches are located in Sapporo, Sendai, Tokyo Branch 1, Tokyo Branch 2, Yokohama, Nagoya, Kyoto, Osaka, Hiroshima, Takamatsu and Fukuoka. The Company has research laboratories at Fuji-Gotemba, Kamakura and Ukima. Its products in oncology include Kytril, Femara, Tarceva, Xeloda, Neutrogin, Rituxan, Herceptin, and Avastin; bone and joint disease products comprise Edirol, Alfarol, Suvenyl, Evista, and Actemra; and renal disease products consist of Renagel, Oxarol, Epogin, and Mircera. The Company also provides products for chronic hepatitis C, which include Copegus, CellCept, Pegasys, Sigmart, and Tamiflu. In addition, it has various development, product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, central nervous system, and other diseases.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K
Short Volume Ratio 0.50

Growth:

1-Year Return 13.19%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Latest Earnings Date N/A
Next Ex-Dividends Date 06/26/15
Dividend Payable Date 03/27/15
Dividend Payout Ratio 0.00%

CHGCF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 49.59
Price/Book 3.22
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar